NPIF II - PXN Equity Finance

Funding rounds backed by NPIF II - PXN Equity Finance.

Export CSV
Funding disclosed in full
$6.7M
Median round
$6.7M
Rounds in calculation
1
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Imperagen

Uses quantum physics simulation and AI to engineer high-performance enzymes for pharma and industrial markets

£5MSeedBiotechUnited Kingdom
7 participantsEnterprise Cheshire + WarringtonGMC Life Sciences Fund By PXN VenturesGreater Manchester Combined AuthorityIQ CapitalNorthern GritstoneNPIF II - PXN Equity FinancePXN Ventures